Drug-discovery platform for high-risk leukemias in children shows promising results

by

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and its affiliated Institute for Research in Immunology and Cancer are working on a large-scale drug discovery project to get there.

Leave A Comment

Your email address will not be published. Required fields are marked *